Description:

E1305 Sensory Neuropathy Form NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3EFA1187-27D1-22F1-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3EFA1187-27D1-22F1-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
  4. 7/8/15
Uploaded on:

July 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

E1305 Sensory Neuropathy Form NCT00588770

INSTRUCTIONS: Complete this form as indicated below and at the end of all protocol therapy. Submit original to the ECOG Coordinating Center. Keep a copy for your files.

Header
Patient demographics
Data amendment
Off Treatment
Off Treatment Report Period (Choose one)
Adverse Events
Were adverse events assessed during this report period (Sensory Neuropathy cycle)
Blood/bone Marrow - Labs
CTC Adverse Event Term
CTC Adverse Event Grade (v4.0 this cycle)
CTC AE Attribution Code
Outcome of Adverse Event
Comments

Similar models